Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 17,396 $ 38,635
Short term investments 8,970 20,534
Accounts receivable 572 5,810
Receivable from public grants 3,141 4,771
Other receivables 2,326 462
Assets held for sale, property and equipment 2,188 0
Prepaid expenses and other current assets 4,087 3,212
Total current assets 38,680 73,424
Property and equipment, net 0 16,992
Operating lease right-of-use assets, non-current 0 3,705
Other non-current assets 0 1,369
Total assets 38,680 95,490
Current liabilities:    
Accounts payable 3,372 4,154
Operating lease liabilities, current 0 859
Accrued expenses and other current liabilities 8,550 10,746
Deferred revenues, current portion 0 20,824
Total current liabilities 11,922 36,583
Deferred revenue, net of current portion 0 18,734
Operating lease liabilities, non-current 0 12,244
Total liabilities 11,922 67,561
Commitments and Contingencies
Stockholders’ equity:    
Convertible preferred stock, $0.001 par value per share, 10,000,000 shares authorized and 15,617 shares issued and outstanding at December 21, 2023 and 2022 0 0
Common stock, $0.001 par value per share, 300,000,000 shares authorized and 98,935,025 and 74,519,103 shares issued and outstanding at December 21, 2023 and 2022, respectively 98 74
Additional paid-in capital 341,596 318,530
Accumulated other comprehensive income 28 (254)
Accumulated deficit (314,964) (290,421)
Total stockholders’ equity 26,758 27,929
Total liabilities and stockholders’ equity $ 38,680 $ 95,490